Does ketoprofen or diclofenac pose the lowest risk to fish?

Journal of Hazardous Materials

Volumn 229-230, Issue , 2012, Pages 100-106

  Cuklev, Filip ^a   Fick, Jerker ^b   Cvijovic, Marija ^a,c   Kristiansson, Erik ^c   Förlin, Lars ^d   Larsson, D G Joakim ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

^c CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Bioconcentration; Fish; Gene expression; Ketoprofen; NSAID

Indexed keywords

BIOCONCENTRATION; BIOCONCENTRATION FACTOR; BLOOD PLASMA; COMPREHENSIVE ANALYSIS; DICLOFENAC; EXPOSURE SYSTEM; HUMAN THERAPEUTICS; KETOPROFEN; META-ANALYSIS; NON-STEROIDAL ANTI-INFLAMMATORY DRUGS; NSAID; PHARMACOLOGICAL RESPONSE; PLASMA CONCENTRATION; PURE WATER; RAINBOW TROUT; SEWAGE EFFLUENTS;

EFFLUENTS; ENVIRONMENTAL IMPACT; GENE EXPRESSION; SEWAGE;

FISH;

DICLOFENAC; KETOPROFEN;

BLOOD; CONCENTRATION (COMPOSITION); DRUG; EFFLUENT; GENE EXPRESSION; META-ANALYSIS; PHYSIOLOGICAL RESPONSE; POLLUTION EXPOSURE; RISK FACTOR; SALMONID; SEWAGE; SURFACE WATER; WILD POPULATION;

ARTICLE; BIOACCUMULATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; FISH; GENE EXPRESSION; NONHUMAN; RAINBOW TROUT; SEWAGE EFFLUENT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE INHIBITORS; DICLOFENAC; FEMALE; GENE EXPRESSION REGULATION; KETOPROFEN; LIVER; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCORHYNCHUS MYKISS; WATER POLLUTANTS, CHEMICAL;

ONCORHYNCHUS MYKISS; SALMONIDAE;

EID: 84863848055     PISSN: 03043894     EISSN: 18733336     Source Type: Journal    
DOI: 10.1016/j.jhazmat.2012.05.077     Document Type: Article

References (48)

1. Fitzsimmons P.N., Fernandez J.D., Hoffman A.D., Butterworth B.C., Nichols J.W. Branchial elimination of superhydrophobic organic compounds by rainbow trout (Oncorhynchus mykiss). Aquat. Toxicol. 2001, 55:23-34.
2. Huggett D.B., Cook J.C., Ericson J.F., Williams R.T. A theoretical model for utilizing mammalian pharmacology and safety data to prioritize potential impacts of human pharmaceuticals to fish. Hum. Ecol. Risk. Assess. 2003, 9:1789-1799.
3. Schreiber R., Gündel U., Franz S., Küster A., Rechenberg B., Altenburger R. Using the fish plasma model for comparative hazard identification for pharmaceuticals in the environment by extrapolation from human therapeutic data. Regul. Toxicol. Pharmacol. 2011, 61:261-275.
4. Oaks J.L., Gilbert M., Virani M.Z., Watson R.T., Meteyer C.U., Rideout B.A., Shivaprasad H.L., Ahmed S., Iqbal Chaudhry M.J., Arshad M., Mahmood S., Ali A., Ahmed Khan A. Diclofenac residues as the cause of vulture population decline in Pakistan. Nature 2004, 427:630-633.
5. Shultz S., Baral H.S., Charman S., Cunningham A.A., Das D., Ghalsasi G.R., Goudar M.S., Green R.E., Jones A., Nighot P., Pain D.J., Prakash V. Diclofenac poisoning is widespread in declining vulture populations across the Indian subcontinent. Proc. Biol. Sci. 2004, 271(Suppl. 5):S458-S460.
6. Pain D.J., Bowden C.G.R., Cunningham A.A., Cuthbert R., Das D., Gilbert M., Jakati R.D., Jhala Y., Khan A.A., Naidoo V., Oaks J.L., Parry-Jones J., Prakash V., Rahmani A., Ranade S.P., Baral H.S., Senacha K.R., Saravanan S., Shah N., Swan G., Swarup D., Taggart M.A., Watson R.T., Virani M.Z., Wolter K., Green R.E. The race to prevent the extinction of South Asian vulture. Bird Conserv. Int. 2008, 18:S30-S48.
7. Naidoo V., Wolter K., Cromarty D., Diekmann M., Duncan N., Meharg A.A., Taggart M.A., Venter L., Cuthbert R. Toxicity of non-steroidal anti-inflammatory drugs to Gyps vultures: a new threat from ketoprofen. Biol. Lett. 2010, 6:339-341.
8. Cuthbert R., Parry-Jones J., Green R.E., Pain D.J. NSAIDs and scavenging birds: potential impacts beyond Asia's critically endangered vultures. Biol. Lett. 2007, 3:91-94.
9. Mulcahy D.M., Tuomi P., Larsen R.S. Differential mortality of male spectacled eiders (Somateria fischeri) and king eiders (Somateria spectabilis) subsequent to anesthesia with propofol, bupivacaine, and ketoprofen. J. Avian Med. Surg. 2003, 1(7):117-123.
10. Brown J.N., Paxéus N., Förlin L., Larsson D.G.J. Variations in bioconcentration of human pharmaceuticals from sewage effluents into fish blood plasma. Environ. Toxicol. Pharmacol. 2007, 24:267-274.
11. Fick J., Lindberg R.H., Parkkonen J., Arvidsson B., Tysklind M., Larsson D.G.J. Therapeutic levels of levonorgestrel detected in blood plasma of fish: results from screening rainbow trout exposed to treated sewage effluents. Environ. Sci. Technol. 2010, 44:2661-2666.
12. Ternes T.A. Occurrence of drugs in German sewage treatment plants and rivers. Water Res. 1998, 32:3245-3260.
13. Tixier C., Singer H.P., Oellers S., Müller S.R., Occurrence Fate of carbamazepine, clofibric acid, diclofenac, ibuprofen, ketoprofen, and naproxen in surface waters. Environ. Sci. Technol. 2003, 3(7):1061-1068.
14. Hoeger B., Kollner B., Dietrich D.R., Hitzfeld B. Water-borne diclofenac affects kidney and gill integrity and selected immune parameters in brown trout (Salmo trutta f. fario). Aquat. Toxicol. 2005, 75:53-64.
15. Mehinto A.C., Hill E.M., Tyler C.R. Uptake and biological effects of environmentally relevant concentrations of the nonsteroidal anti-inflammatory pharmaceutical diclofenac in rainbow trout (Oncorhynchus mykiss). Environ. Sci. Technol. 2010, 44:2176-2182.
16. Schwaiger J., Ferling H., Mallow U., Wintermayr H., Negele R.D. Toxic effects of the non-steroidal anti-inflammatory drug diclofenac. Part I: Histopathological alterations and bioaccumulation in rainbow trout. Aquat. Toxicol. 2004, 68:141-150.
17. Triebskorn R., Casper H., Heyd A., Eikemper R., Kohler H.R., Schwaiger J. Toxic effects of the non-steroidal anti-inflammatory drug diclofenac. Part II: Cytological effects in liver, kidney, gills and intestine of rainbow trout (Oncorhynchus mykiss). Aquat. Toxicol. 2004, 68:151-166.
18. Cuklev F., Kristiansson E., Fick J., Asker N., Förlin L., Larsson D.G.J. Diclofenac in fish: blood plasma levels similar to human therapeutic levels affect global hepatic gene expression. Environ. Toxicol. Chem. 2011, 30:2126-2134.
19. Lahti M., Brozinski J.-M., Jylhä A., Kronberg L., Oikari A. Uptake from water, biotransformation, and biliary excretion of pharmaceuticals by rainbow trout. Environ. Toxicol. Chem. 2011, 3(0):1403-1411.
20. Hardman J.G., Limbard L.E., Gilman A.G. The Pharmacological Basis of Therapeutics 2001, McGraw-Hill, NY, USA.
21. Juhlin T., Björkman S., Gunnarsson B., Fyge å, Roth B., Höglund P. Acute administration of diclofenac but possibly not long term low dose aspirin, causes detrimental renal effects in heart failure patients treated with ACE-inhibitors. Eur. J. Heart. Fail. 2004, 6:909-916.
22. European Union Proposal for a Directive of the European Parliament and of the Council Amending Directives 2000/60/EC and 2008/105/EC as Regards Priority Substances in the Field of Water Policy 2012, Water framework directive, Brussels, Belgium.
23. Thibaut R., Schnell S., Porte C. The interference of pharmaceuticals with endogenous and xenobiotic metabolizing enzymes in carp liver: an in vitro study. Environ. Sci. Technol. 2006, 40:5154-5160.
24. Roos V., Gunnarsson L., Fick J., Larsson D.G.J., Rudén C. Prioritising pharmaceuticals for environmental risk assessment: towards adequate and feasible first-tier selection. Sci. Total. Environ. 2012, 421-422:102-110.
25. Kullgren A., Samuelsson L.M., Larsson D.G.J., Björnsson B.T., Bergman E.J. A metabolomics approach to elucidate effects of food deprivation in juvenile rainbow trout (Oncorhynchus mykiss). Am. J. Physiol: Regul. Integr. Comp. Physiol. 2010, 299:R1440-R1448.
26. Nallani G.C., Paulos P.M., Constantine L.A., Venables B.J., Huggett D.B. Bioconcentration of ibuprofen in fathead minnow (Pimephales promelas) and channel catfish (Ictalurus punctatus). Chemosphere 2011, 84:1371-1377.
27. Kristiansson E., Asker N., Forlin L., Larsson D.G.J. Characterization of the Zoarces viviparus liver transcriptome using massively parallel pyrosequencing. BMC Genomics 2009, 10:345.
28. Cuklev F., Gunnarsson L., Cvijovic M., Kristiansson E., Rutgersson C., Björlenius B., Larsson D.G.J. Global hepatic gene expression in rainbow trout exposed to sewage effluents: a comparison of different sewage treatment technologies. Sci. Total. Environ. 2012, 427-428:106-114.
29. Gunnarsson L., Kristiansson E., Rutgersson C., Sturve J., Fick J., Förlin L., Larsson D.G.J. Pharmaceutical industry effluent diluted 1:500 affects global gene expression, cytochrome P4501A activity and plasma phosphate in fish. Environ. Toxicol. Chem. 2009, 28:2639-2647.
30. Lennquist A., Asker N., Kristiansson E., Brenthel A., Björnsson B.T., Kling P., Hultman M., Larsson D.G.J., Förlin L. Physiology and mRNA expression in rainbow trout (Oncorhynchus mykiss) after long-term exposure to the new antifoulant medetomidine. Comp. Biochem. Physiol. C: Pharmacol. Toxicol. 2011, 154:234-241.
31. R Development Core Team R: A Language and Environment for Statistical Computing 2010, R Foundation for Statistical Computing, Vienna, Austria.
32. Smyth G., Limma Linear models for microarray data. Bioinformatics and Computational Biology Solutions Using R and Bioconductor 2005, 397-420. Springer, New York. R. Gentleman, V.J. Carey, W. Huber, R.A. Irizarry, S. Dudoit (Eds.).
33. Smyth G.K. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 2004, 3:Article3.
34. Schulz M., Schmoldt A. Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics. Pharmazie 2003, 58:447-474.
35. Apoteket A.B. Selling Statistics of Human Pharmaceuticals 2010, http://www.apotekensservice.se/Om-Apotekens-Service/Infrastrukturtjanster/Statistik/.
36. Lindqvist N., Tuhkanen T., Kronberg L. Occurrence of acidic pharmaceuticals in raw and treated sewages and in receiving waters. Water Res. 2005, 39:2219-2228.
37. Daughton C.G., Ternes T.A. Pharmaceuticals and personal care products in the environment: agents of subtle change?. Environ. Health Perspect. 1999, 107:907-938.
38. Matsuo H., Sakamoto H., Arizono K., Shinohara R. Behavior of pharmaceuticals in waste water treatment plant in Japan. Bull. Environ. Contam. Toxicol. 2011, 87:31-35.
39. Rosal R., Rodríguez A., Perdigón-Melón J.A., Petre A., García-Calvo E., Gómez M.J., Agüera A., Fernández-Alba A.R. Occurrence of emerging pollutants in urban wastewater and their removal through biological treatment followed by ozonation. Water Res. 2010, 44:578-588.
40. Fernández C., González-Doncel M., Pro J., Carbonell G., Tarazona J.V. Occurrence of pharmaceutically active compounds in surface waters of the Henares-Jarama-Tajo River system (Madrid, Spain) and a potential risk characterization. Sci. Total. Environ. 2010, 408:543-551.
41. Liu C., Gin K.Y.H., Chang V.W.C., Goh B.P.L., Reinhard M. Novel perspectives on the bioaccumulation of PFCs - the concentration dependency. Environ. Sci. Technol. 2011, 45:9758-9764.
42. Contardo-Jara V., Lorenz C., Pflugmacher S., Nützmann G., Kloas W., Wiegand C. Molecular effects and bioaccumulation of levonorgestrel in the non-target organism Dreissena polymorpha. Environ. Pollut. 2011, 159:38-44.
43. Kondo T., Yamamoto H., Tatarazako N., Kawabe K., Koshio M., Hirai N., Morita M. Bioconcentration factor of relatively low concentrations of chlorophenols in Japanese medaka. Chemosphere 2005, 61:1299-1304.
44. Guideline on the Environmental Risk Assessment of Medicinal Products for Human Use 2006, http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/10/WC500003978.pdf.
45. U.S.EPA Guidelines for Ecological Risk Assessment 1998, http://www.epa.gov/raf/publications/guidelines-ecological-risk-assessment.htm.
46. Berninger J.P., Brooks B.W. Leveraging mammalian pharmaceutical toxicology and pharmacology data to predict chronic fish responses to pharmaceuticals. Toxicol. Lett. 2010, 193:69-78.
47. Theil E.C. Ferritin: structure gene regulation, and cellular function in animals, plants, and microorganisms. Ann. Rev. Biochem. 1987, 5(6):289-315.
48. Bhandari K., Venables B. Ibuprofen bioconcentration and prostaglandin E2 levels in the bluntnose minnow Pimephales notatus. Comp. Biochem. Physiol. C: Toxicol. Pharmacol. 2011, 153:251-257.